HOXB9 and colon adenocarcinoma: However, increased expression of HOXB9 showed better overall survival in colon adenocarcinoma, pancreatic ductal adenocarcinoma and gastric carcinoma patients15–17, indicating HOXB9 played an opposite role in these cancer progression.